长兴宜生药物科技有限公司
长兴宜生药物科技有限公司
长兴宜生药物科技有限公司
长兴宜生药物科技有限公司
Main Products:N-BOC-3-羟基哌啶, (S)-1-叔丁氧羰基-3-羟基哌啶, 3-氨基-4-氰基-5-(4-苯氧基苯基)吡唑,
View moreAbout Us
Contact Supplier
L-Glutamicacid, 1-(1,1-dimethylethyl) ester
Chemicals/Pharmaceutical & Biochemical/Glutamic AcidNegotiable
Send Inquiry
N,N'-bis(1-methylpropyl)ethanimidamide
Chemicals/Heterocyclic Compounds/Organic IntermediatesNegotiable
Send Inquiry
Ethanimidamide, N,N'-bis(1-methylethyl)-
Chemicals/Ketones/Methyl Vinyl KetoneNegotiable
Send Inquiry
Methanimidamide, N,N'-bis(1-methylethyl)-
Chemicals/Heterocyclic Compounds/Organic IntermediatesNegotiable
Send Inquiry
Copper(II) acetylacetonate
Chemicals/Heterocyclic Compounds/Organic IntermediatesNegotiable
Send Inquiry
4,7-dibromo-2-isobutyl-2H-benzo[d][1,2,3]triazole
Chemicals/Other Organic Raw Materials/Aromatic CompoundsNegotiable
Send Inquiry
9H-Carbazole-9-propanenitrile, 3-nitro-
Chemicals/Heterocyclic Compounds/CarbazoleNegotiable
Send Inquiry
2-Methyl-1,2-benzothiazol-3(2H)-one
Chemicals/Heterocyclic Compounds/ThiazoleNegotiable
Send Inquiry
Changxing Yisheng Pharmaceutical Technology Co., Ltd. is a company engaged in the research and development, production, and technical services of generic drugs. It was established on February 3, 2021, and is located in Changxing County, Huzhou City, Zhejiang Province, covering an area of 20 acres.
· Using generic drugs as the market entry point;
· With enzyme-catalyzed chiral synthesis and asymmetric hydrogenation synthesis technologies as the core competitiveness of the enterprise;
· Aiming at the high-end market, it is a high-tech pharmaceutical enterprise integrating the research and development, production, and sales of pharmaceutical intermediates, non-natural amino acids, short peptides, and active pharmaceutical ingredients.
